Claude Bertrand

Claude Bertrand is an experienced pharmaceutical executive with a robust background in research and development. Currently serving as the Executive Vice President R&D and Chief Scientific Officer at Servier, Claude has previously held similar roles at Ipsen, where responsibilities included serving as ARIIS President. Prior positions include Global Vice President roles at AstraZeneca, with a focus on established brands and discovery, and a Director position at Pfizer. Claude's career began at Roche as a Principal Scientist. Education includes a Ph.D. in Pharmacology from the University of Strasbourg and post-doctoral training in Neurogenic Inflammation at the University of California, San Francisco.